Chemoinformaics analysis of Ethyl Beta-D-Galactopyranoside
| Molecular Weight | 208.21 | nRot | 3 |
| Heavy Atom Molecular Weight | 192.082 | nRig | 6 |
| Exact Molecular Weight | 208.095 | nRing | 1 |
| Solubility: LogS | -0.234 | nHRing | 1 |
| Solubility: LogP | -1.19 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 28.8407 |
| nHD | 4 | BPOL | 19.5233 |
| QED | 0.421 |
| Synth | 3.503 |
| Natural Product Likeliness | 2.348 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.297 |
| HIA | 0.768 |
| CACO-2 | -5.303 |
| MDCK | 0.000201764 |
| BBB | 0.258 |
| PPB | 0.160758 |
| VDSS | 0.463 |
| FU | 0.745528 |
| CYP1A2-inh | 0.021 |
| CYP1A2-sub | 0.082 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.51 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.073 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.023 |
| CL | 1.958 |
| T12 | 0.747 |
| hERG | 0.059 |
| Ames | 0.456 |
| ROA | 0.071 |
| SkinSen | 0.231 |
| Carcinogencity | 0.044 |
| EI | 0.927 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.898921 |